Bill Kane joins Almac

Company: Almac Group

Takes role of director of quality assurance and regulatory compliance

Bill Kane has joined Almac’s Clinical Technologies division as director of quality assurance (QA) and regulatory compliance. He will be responsible for supporting internal, client, and agency audits, as well as improving internal quality and compliance programmes.

Kane has more than 10 years of experience in the biopharmaceutical industry and an additional five years supporting toxicological laboratories. He has served in a variety of capacities involving management of GxP compliance, computer systems validation, system development lifecycle (SDLC) process controls, information security programmes, Sarbanes Oxley compliance, and records management.

Kane joins Almac after spending 10 years at Johnson and Johnson’s Pharmaceutical Supply Chain organisation as a global information technology director, compliance and quality systems.

You may also like

Manufacturing

Almac’s Charnwood facility receives FDA approval for oral dose development and manufacturing

The facility, which focuses on the manufacture of high potency oral dosage forms, has been approved for use by the FDA
Manufacturing

Almac completes “outstanding” grade by the KTP

The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development
Manufacturing

Almac Sciences Ireland secures HPRA certification

This additional certification enables Almac to perform biologics testing for the determination of product quality attributes
Regulatory

Almac receives product approval by MHRA and Health Canada

The company’s site provides a range of solutions for blister packs, stickpacks, and kitting
Packaging

Enhancing clinical trial supply with JTM: part I

In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a rapidly growing and ageing population and develop innovative personalised medicines. Almac has responded to these demands with a Just-in-Time Manufacturing solution that fulfils the requirements of a high value, time sensitive clinical supply chain. Dr Kevin Robinson spoke to Natalie Balanovsky, Just-in-Time Manufacturing Solutions Manager, and Mark Rohlfing, Vice President of Operations, to find out more
Regulatory

Almac welcomes confirmation that Northern Ireland will remain aligned with the EU post-Brexit

Move offers Almac clients unique, unfettered and flexible access to both the UK and European markets
Regulatory

Almac Group supports two COVID-19 clinical studies in sub-Saharan Africa

Grant awarded from the COVID-19 Therapeutics Accelerator, an Initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard
Subscribe now